Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vinpocetine for acute ischaemic stroke.

D Bereczki1, I Fekete

  • 1Department of Neurology, University Medical School of Debrecen, Nagyerdei krt. 98, Debrecen, Hungary, H-4012. bereczki@jaguar.dote. hu

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary

Vinpocetine is a drug used for stroke treatment. Current evidence is insufficient to determine its effectiveness in improving survival or reducing dependency in acute ischemic stroke patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic.

European journal of neurology·2020
Same author

The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection.

European journal of neurology·2020
Same author

Demand for neurological services in Central Eastern Europe: a 10-year national survey in Hungary.

European journal of neurology·2018
Same author

Health-Related Quality of Life in Migraine Without Aura Based on Attack Frequency: A time Trade-Off Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Valproate treatment normalizes EEG functional connectivity in successfully treated idiopathic generalized epilepsy patients.

Epilepsy research·2014
Same author

Comparing ischaemic stroke in six European countries. The EuroHOPE register study.

European journal of neurology·2014

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Vasoactive and neuroprotective drugs are utilized in stroke management in various regions.
  • Vinpocetine is one such drug with potential therapeutic applications.

Purpose of the Study:

  • To evaluate the efficacy and safety of vinpocetine for treating acute ischemic stroke.
  • Assessing vinpocetine's impact on patient survival and functional dependency.

Main Methods:

  • A systematic review of randomized controlled trials (RCTs) was conducted.
  • Searches included Cochrane Stroke Group trials register and Medline, supplemented by direct contact with researchers and pharmaceutical companies.
  • Inclusion criteria focused on RCTs of vinpocetine versus placebo or other treatments initiated within 14 days of stroke onset.

Main Results:

  • Only one trial with 40 participants (33 with reported data) met the inclusion criteria.
  • The trial found no significant difference in mortality or dependency between vinpocetine and placebo groups.
  • No adverse events were reported in the included study.

Conclusions:

  • The existing evidence base is inadequate to establish the effect of vinpocetine on survival or dependency in acute ischemic stroke.
  • Further high-quality randomized controlled trials are necessary to ascertain the role of vinpocetine in stroke care.

Related Experiment Videos